Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate

As one of the major therapeutic options for cancer treatment, chemotherapy has limited selectivity against cancer cells. Consequently, this therapeutic strategy offers a small therapeutic window with potentially high toxicity and thus limited efficacy of doses that can be tolerated by patients. Anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheyi, Rotimi, de la Torre, Beatriz G., Albericio, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874516/
https://www.ncbi.nlm.nih.gov/pubmed/35214128
http://dx.doi.org/10.3390/pharmaceutics14020396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874516/
https://www.ncbi.nlm.nih.gov/pubmed/35214128
http://dx.doi.org/10.3390/pharmaceutics14020396

Ejemplares similares